Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06958523 · ClinicalTrials.gov registry record

Apple Health Study

A clinical trial of Aging and Sleep, sponsored by Apple.

Recruiting
Registry status
500,000
Enrollment target
2
Study locations

NCT06958523 is a study of Aging and Sleep that is actively recruiting participants, run by Apple. The registered enrollment target is 500,000 participants, above the 286-participant average among 262 other Aging trials with a reported enrollment target (174725% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06958523, a study of Aging and Sleep, is actively recruiting participants, sponsored by Apple.

RECRUITING
Registry status
500,000 participants
Enrollment target
2
Study locations

Study Summary

The Apple Health Study aims to build a diverse and inclusive group of participants to help researchers advance our understanding of how signals and information collected from apps and devices relate to health and may be used to predict, detect, monitor, and manage changes in health. To enroll, US residents who have an iPhone can download the Apple Research app from the App Store and go through the introduction and informed consent for the Apple Health Study. This study is fully remote, and all are invited to enroll if the eligibility criteria are met. Participants will be asked to complete tasks and surveys, using their iPhone and Apple Research app which include: * Selecting the types of data they would like to share with the study such as health and sensor data * Completing tasks and surveys including areas such as personal demographic information, personal medical history, family history, and social determinants of health

Study Locations (2)

District of Columbia

  • MCRA - Washington D.C.

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 500,000 participants
Start Date 2025-02-12
Est. Completion 2030-02

Sponsor

Apple

12 total trials

What the Registry Record Tells You About NCT06958523

The ClinicalTrials.gov registry entry for NCT06958523 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 286-participant average among 262 other Aging trials with a reported enrollment target (174725% higher). The listed sponsor is Apple, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Aging appearing as the primary indexed condition, and to 0 interventions.

NCT06958523 reports 2 study locations spanning 2 distinct geographic areas - top geographies include District of Columbia, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06958523 about?

NCT06958523 is a clinical study titled "Apple Health Study". The Apple Health Study aims to build a diverse and inclusive group of participants to help researchers advance our understanding of how signals and information collected from apps and devices relate to health and may be used to predict, detect, monitor, and manage changes in health. To enroll, US r...

What is the current status of trial NCT06958523?

This trial is currently recruiting. The enrollment target is 500,000 participants. The study started on 2025-02-12. Estimated completion is 2030-02.

What conditions does trial NCT06958523 study?

This clinical trial studies the following conditions: Aging, Sleep, Mental Health, Exercise, Metabolic Health.

Who is sponsoring clinical trial NCT06958523?

This trial is sponsored by Apple, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06958523 being conducted?

This trial has 2 study locations across District of Columbia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.